Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | XYL | Common Stock | Options Exercise | $229K | +3.6K | +8.58% | $63.55 | 45.6K | Jun 1, 2021 | Direct | |
transaction | XYL | Common Stock | Sale | -$430K | -3.6K | -7.9% | $119.31 | 42K | Jun 1, 2021 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | XYL | Stock Option (Right to Buy) | Options Exercise | $0 | -3.6K | -19.76% | $0.00 | 14.6K | Jun 1, 2021 | Common | 3.6K | $63.55 | Direct | F3 |
Id | Content |
---|---|
F1 | The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 15, 2021. |
F2 | This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). Shares were executed at a range of prices from $118.96 to $119.60. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
F3 | The May 7, 2020 option grant vests in one third increments on February 27, 2021, February 27, 2022 and February 27, 2023. |